Decreasing self-reported cognitive biases and increasing clinical insight through meta-cognitive training in patients with chronic schizophrenia

Journal of Behavior Therapy and Experimental Psychiatry
Łukasz GawędaAndrzej Kokoszka

Abstract

The aim of this study was to assess the impact of meta-cognitive training (MCT) on cognitive biases, symptoms, clinical insight, and general functioning among low-level functioning persons diagnosed with chronic schizophrenia who were attending a daily Community Social Support Group Program; we compared the treatment-as-usual (TAU) condition with the MCT + TAU condition. Forty-four patients diagnosed with chronic schizophrenia were allocated to either the MCT + treatment-as-usual condition or the treatment-as-usual (TAU) condition. Delusion and hallucination severity, cognitive biases, clinical insight, and global functioning were assessed pre- and post-treatment (clinical trial NCT02187692). No significant changes were found in symptom severity as measured with the PSYRATS. Conversely, a medium to large effect size was observed for delusional ideation changes when assessed by the self-report measure (Paranoia Checklist). MCT was found to ameliorate cognitive biases as measured by the self-report scale at large effect size, however, no changes in jumping to conclusions (the Fish Task) and theory of mind deficits ("Reading the Mind in the Eyes" Test) were found in the behavioral tasks. MCT increased insight at large effect size....Continue Reading

References

Mar 31, 2001·Journal of Child Psychology and Psychiatry, and Allied Disciplines·S Baron-CohenI Plumb
Jun 26, 2003·The Journal of Clinical Psychiatry·Scott W Woods
May 3, 2005·The British Journal of Psychiatry : the Journal of Mental Science·Daniel FreemanGraham Dunn
Jul 12, 2005·The British Journal of Clinical Psychology·Steffen Moritz, Todd S Woodward
Oct 9, 2007·Current Opinion in Psychiatry·Steffen Moritz, Todd S Woodward
Nov 14, 2007·Journal of Clinical Epidemiology·George F BormWim A J G Lemmens
Jun 13, 2009·Schizophrenia Bulletin·Kerry RossPhilippa Garety
Dec 4, 2009·Schizophrenia Bulletin·Julie KreyenbuhlUNKNOWN Schizophrenia Patient Outcomes Research Team (PORT)
Feb 20, 2010·Journal of Behavior Therapy and Experimental Psychiatry·Julia AghotorDaniela Roesch-Ely
Feb 1, 2011·Behaviour Research and Therapy·S MoritzT S Woodward
Aug 29, 2012·Schizophrenia Bulletin·Bart D PetersLieuwe de Haan
Sep 4, 2012·Journal of Behavior Therapy and Experimental Psychiatry·H WallerT Craig
Jan 12, 2013·Schizophrenia Research·Gerdina H M PijnenborgAndré Aleman
Oct 5, 2013·Schizophrenia Research·Debbie M WarmanPaul Lysaker
Nov 2, 2013·European Psychiatry : the Journal of the Association of European Psychiatrists·J FavrodC Bonsack
Nov 5, 2013·Schizophrenia Research·Steffen MoritzDaniela Roesch-Ely
May 29, 2014·Clinical Psychology Review·Steffen MoritzTodd S Woodward
Jul 30, 2015·The Australian and New Zealand Journal of Psychiatry·Isabelle Granville SmithUté Vollmer-Conna

❮ Previous
Next ❯

Citations

Feb 19, 2016·Psychological Medicine·B van OosterhoutM van der Gaag
Oct 23, 2015·Psychological Medicine·S MoritzT S Woodward
Sep 7, 2016·Schizophrenia Research·Steffen MoritzMona Dietrichkeit
Jun 6, 2020·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Tom BurkeNiall Pender
Jan 21, 2018·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Paul H LysakerJenifer L Vohs
Nov 21, 2019·International Journal of Environmental Research and Public Health·Miguel Simón-Expósito, Elena Felipe-Castaño
Sep 1, 2019·Schizophrenia Research·Ryotaro IshikawaMasahito Hosono
Mar 19, 2021·Revista colombiana de psiquiatría·Vanessa AcuñaHumberto Villalobos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here